SAM
ANTH

Sectoral Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Sectoral Asset Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-30,995
Closed -$476K – 73
2014
Q3 		$476K Buy
30,995
+3,544
+13% +$74.6K 0.02% 66
2014
Q2 		$744K Sell
27,451
-232
-0.8% -$5.73K 0.03% 63
2014
Q1 		$742K Buy
+27,683
New +$703K 0.03% 57

Other funds holding ANTH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Sectoral Asset Management's ANTH Position: Q4 2014 in Review

Sectoral Asset Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2014, closing a stake of 30,995 shares — an estimated $476K sold.

Sectoral Asset Management first reported a position in ANTH in Q1 2014 and held it in 3 quarters. The position peaked at $744K in Q2 2014. 37 funds tracked by Wall St. Rank hold ANTH as of Q4 2014.

  • Sectoral Asset Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Sectoral Asset Management sold 30,995 Anthera Pharmaceuticals, Inc. shares in Q4 2014, an estimated $476K.
  • Sectoral Asset Management first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • Sectoral Asset Management's Anthera Pharmaceuticals, Inc. position peaked at $744K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2014.

Based on Sectoral Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.